Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.

Saito, Yoji; Yokota, Takaaki; Arai, Masatsugu; Tada, Yukio; Sumitani, Masahiko

Saito, Yoji; Yokota, Takaaki; Arai, Masatsugu; Tada, Yukio; Sumitani, Masahiko.

Afiliación

Saito Y; Department of Anesthesiology, Shimane University Hospital, Shimane, Japan.
Yokota T; Project Management Department, Shionogi & Co., Ltd, Osaka, Japan, takaaki.yokota@shionogi.co.jp.
Arai M; Business Development Department, Shionogi & Co., Ltd, Osaka, Japan.
Tada Y; Biostatistics Center, Shionogi & Co., Ltd, Osaka, Japan.
Sumitani M; Department of Pain and Palliative Medicine, The University of Tokyo Hospital, Tokyo, Japan.

J Pain Res ; 12: 127-138, 2019.

Article en En | MEDLINE | ID: mdl-30613161

Palabras clave

PAC-QOL; PAC-SYM; bowel function; clinical studies; opioids; patient assessment of constipation QOL; patient assessment of constipation symptoms; peripherally-acting µ-opioid-receptor antagonists

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Pain Res Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google